About Jason Pesterfield

I’ve had the honor and privilege of serving in the MedTech space for 25+ years with most of my career focused on leading efforts around developing and commercializing advanced technologies and building high-performance cultures. I’ve established a track record of developing executable strategies, building talented teams, raising growth capital, and delivering results that create stakeholder value.

At Optellum we are revolutionizing the lung cancer care pathway through the power of artificial intelligence. Our Virtual Nodule Clinic is the world’s first and only FDA cleared AI-based early lung cancer decision support software designed to help clinicians identify and track at risk patients and make optimal clinical management decisions. Our AI-based digital biomarker has robust clinical validation, FDA approval, and is being adopted by thought leading physicians and institutions around the world.

Prior to Optellum I was the President and CEO of Veran Medical Technologies which was acquired by Olympus Corporation in December 2020. Prior to Veran I was with Stryker Corporation where I held a variety of leadership positions, including Global Vice President and General Manager of the Surgical Navigation business.